LEGISLATIVE BUDGET BOARD

Austin, Texas

FISCAL NOTE, 86TH LEGISLATIVE REGULAR SESSION

April 24, 2019

TO:	Honorable Senfronia Thompson, Chair, House Committee on Public Health
FROM:	John McGeady, Assistant Director     Sarah Keyton, Assistant Director Legislative Budget Board
IN RE:	HB2766 by Zerwas (Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.), Committee Report 1st House, Substituted

No significant fiscal implication to the State is anticipated.

The bill would amend the Government Code, Health and Safety Code, and Occupations Code relating to electronically prescribing controlled substance prescriptions under the Texas Controlled Substances Act.

The Comptroller of Public Accounts, Department of Public Safety, Texas Medical Board, Board of Dental Examiners, Board of Pharmacy, and Board of Veterinary Medical Examiners indicate that the duties and responsibilities associated with implementing the provisions of the bill could be accomplished by utilizing existing resources.

Local Government Impact

No fiscal implication to units of local government is anticipated.

Source Agencies:

405 Department of Public Safety, 503 Texas Medical Board, 515 Board of Pharmacy, 304 Comptroller of Public Accounts, 504 Texas State Board of Dental Examiners, 578 Board of Veterinary Medical Examiners

LBB Staff:

WP, AKi, SGr, ESt